President's Malaria Initiative contributing to 'major progress' against disease, should be expanded

NewsGuard 100/100 Score

In this post in The Hill's "Congress Blog," Kent Campbell, director of the Malaria Control Program at PATH, and Jonathon Simon, chair of the Department of International Health and director of the Center for Global Health and Development at the Boston University School of Public Health, write that "major progress has been made in the fight against malaria, thanks in large part to the efforts of the President's Malaria Initiative (PMI)," and call the effort "a shining example of the profound impact the U.S. is making in global health." They highlight a "recent external review of the first five years of its work," which "shows substantial progress toward PMI's goal of cutting malaria deaths by half in 15 African countries."

"According to evaluators, PMI is well-positioned to expand the U.S. government's (USG) malaria control efforts moving forward," they continue and discuss the PMI's key strengths as identified in the review. According to Campbell and Simon, these include "[e]ffective leadership, strong management, and bipartisan support," as well as the support of national entities in the field "so they can assume responsibility effectively." They note the evaluation "also offered recommendations as PMI plans for the future, and the simplest recommendation is also the most emblematic of the program's success: PMI should expand." They conclude, "Now more than ever, we must build on PMI's success and expand its reach so it can help high-burden countries carry their recent gains into the next decade" (8/7).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New malaria vaccine strain shows promise in preclinical trials